Inventor
MCWHERTER CHARLES A
US36 patents
⚠️ This page may combine multiple inventors who share the name “MCWHERTER CHARLES A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CYMABAY THERAPEUTICS INC
21 patentsUS9486428B2Nov 8, 2016
Treatment of intrahepatic cholestatic diseases
CYMABAY THERAPEUTICS INC14 citations92
US10512622B2Dec 24, 2019
Treatment of intrahepatic cholestatic diseases
CYMABAY THERAPEUTICS INC4 citations83
US10272058B2Apr 30, 2019
Treatment of intrahepatic cholestatic diseases
CYMABAY THERAPEUTICS INC5 citations83
US9808436B2Nov 7, 2017
Treatment of intrahepatic cholestatic diseases
CYMABAY THERAPEUTICS INC6 citations83
US9439891B2Sep 13, 2016
Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent
CYMABAY THERAPEUTICS INC3 citations82
US9433612B2Sep 6, 2016
Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent
CYMABAY THERAPEUTICS INC3 citations82
US10828273B2Nov 10, 2020
Treatment of intrahepatic cholestatic diseases
CYMABAY THERAPEUTICS INC1 citations72
US10813895B2Oct 27, 2020
Treatment of intrahepatic cholestatic diseases
CYMABAY THERAPEUTICS INC1 citations72
US10813896B2Oct 27, 2020
Treatment of intrahepatic cholestatic diseases
CYMABAY THERAPEUTICS INC1 citations72
US10478411B2Nov 19, 2019
Treatment of intrahepatic cholestatic diseases
CYMABAY THERAPEUTICS INC1 citations72
US10220011B2Mar 5, 2019
Treatment of intrahepatic cholestatic diseases
CYMABAY THERAPEUTICS INC2 citations72
US9060987B2Jun 23, 2015
Methods for treating gout flares
CYMABAY THERAPEUTICS INC5 citations71
US11596614B2Mar 7, 2023
Treatment of intrahepatic cholestatic diseases
CYMABAY THERAPEUTICS INC0 citations62
US11406611B2Aug 9, 2022
Treatment of intrahepatic cholestatic diseases
CYMABAY THERAPEUTICS INC0 citations62
US11224580B2Jan 18, 2022
Treatment of intrahepatic cholestatic diseases
CYMABAY THERAPEUTICS INC0 citations62
US11000494B2May 11, 2021
Treatment of intrahepatic cholestatic diseases
CYMABAY THERAPEUTICS INC0 citations62
US10292983B2May 21, 2019
Oxymethylene aryl compounds for treating inflammatory gastrointestinal diseases or gastrointestinal conditions
CYMABAY THERAPEUTICS INC1 citations62
US9801860B2Oct 31, 2017
Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent
CYMABAY THERAPEUTICS INC1 citations60
US10137112B2Nov 27, 2018
Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent
CYMABAY THERAPEUTICS INC0 citations50
US9150567B2Oct 6, 2015
Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts
CYMABAY THERAPEUTICS INC0 citations50
US10098843B2Oct 16, 2018
Compositions of 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
CYMABAY THERAPEUTICS INC0 citations47
MONSANTO TECHNOLOGY LLC
4 patentsUS6639054B1Oct 28, 2003
Preparation of deallergenized proteins and permuteins
MONSANTO TECHNOLOGY LLC80 citations96
US7381556B2Jun 3, 2008
Nucleic acids encoding deallergenized proteins and permuteins
MONSANTO TECHNOLOGY LLC2 citations61
US7238511B2Jul 3, 2007
Preparation of deallergenized proteins and permuteins
MONSANTO TECHNOLOGY LLC0 citations50
US6943002B2Sep 13, 2005
Preparation of deallergenized proteins and permuteins
MONSANTO TECHNOLOGY LLC0 citations50